By Ethan Covey
The recombinant zoster vaccine (RZV; Shingrix, GSK) for herpes has been found to be very effective, even in frail patients.
While RZV is highly effective in older adults, there are limited data about how well many vaccines and treatments work in frail individuals, according to a presentation at IDWeek 2020 (abstract 5).
“Herpes zoster can negatively impact older adults’ health and quality of life,” said Melissa K. Andrew, MD, PhD, a staff geriatrician and professor